Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard LeDuc

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
The Biochemical Journal|October 27, 2006
Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sitesBrian J Holleran, Marie-Eve Beaulieu, Christophe D Proulx, et al.
Journal of Medicinal Chemistry|February 12, 2010
The amino-terminus of angiotensin II contacts several ectodomains of the angiotensin II receptor AT1Dany Fillion, Guillaume Lemieux, Luta Luse Basambombo, et al.
The Journal of Biological Chemistry|October 27, 2007
Proteinase-activated receptor-2 induces cyclooxygenase-2 expression through beta-catenin and cyclic AMP-response element-binding proteinHongying Wang, Shoubin Wen, Nigel W Bunnett, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|August 20, 2002
Leukocyte elastase inhibition therapy in cystic fibrosis: role of glycosylation on the distribution of alpha-1-proteinase inhibitor in blood versus lungAndré M Cantin, Donald E Woods, Diane Cloutier, et al.
Journal of Medicinal Chemistry|November 12, 2014
Analysis of subpocket selectivity and identification of potent selective inhibitors for matriptase and matriptase-2Dominic Duchêne, Eloïc Colombo, Antoine Désilets, et al.
Endocrinology|November 26, 2002
A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signalingPatrice C Leclerc, Mannix Auger-Messier, Pascal M Lanctot, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 4, 2014
Biased signaling regulates the pleiotropic effects of the urotensin II receptor to modulate its cellular behaviorsCédric Brulé, Nicolas Perzo, Jane-Eileen Joubert, et al.
British Journal of Pharmacology|March 28, 2006
S-nitrosylation of cysteine 289 of the AT1 receptor decreases its binding affinity for angiotensin IIPatrice C Leclerc, Pascal M Lanctot, Mannix Auger-Messier, et al.
Molecular Pharmacology|May 30, 2008
Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptorChristophe D Proulx, Brian J Holleran, Antony A Boucard, et al.
The Journal of Biological Chemistry|December 11, 2012
Critical hydrogen bond formation for activation of the angiotensin II type 1 receptorJérôme Cabana, Brian Holleran, Marie-Ève Beaulieu, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
The Biochemical Journal|October 27, 2006
Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sitesBrian J Holleran, Marie-Eve Beaulieu, Christophe D Proulx, et al.
Journal of Medicinal Chemistry|February 12, 2010
The amino-terminus of angiotensin II contacts several ectodomains of the angiotensin II receptor AT1Dany Fillion, Guillaume Lemieux, Luta Luse Basambombo, et al.
The Journal of Biological Chemistry|October 27, 2007
Proteinase-activated receptor-2 induces cyclooxygenase-2 expression through beta-catenin and cyclic AMP-response element-binding proteinHongying Wang, Shoubin Wen, Nigel W Bunnett, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|August 20, 2002
Leukocyte elastase inhibition therapy in cystic fibrosis: role of glycosylation on the distribution of alpha-1-proteinase inhibitor in blood versus lungAndré M Cantin, Donald E Woods, Diane Cloutier, et al.
Journal of Medicinal Chemistry|November 12, 2014
Analysis of subpocket selectivity and identification of potent selective inhibitors for matriptase and matriptase-2Dominic Duchêne, Eloïc Colombo, Antoine Désilets, et al.
Endocrinology|November 26, 2002
A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signalingPatrice C Leclerc, Mannix Auger-Messier, Pascal M Lanctot, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 4, 2014
Biased signaling regulates the pleiotropic effects of the urotensin II receptor to modulate its cellular behaviorsCédric Brulé, Nicolas Perzo, Jane-Eileen Joubert, et al.
British Journal of Pharmacology|March 28, 2006
S-nitrosylation of cysteine 289 of the AT1 receptor decreases its binding affinity for angiotensin IIPatrice C Leclerc, Pascal M Lanctot, Mannix Auger-Messier, et al.
Molecular Pharmacology|May 30, 2008
Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptorChristophe D Proulx, Brian J Holleran, Antony A Boucard, et al.
The Journal of Biological Chemistry|December 11, 2012
Critical hydrogen bond formation for activation of the angiotensin II type 1 receptorJérôme Cabana, Brian Holleran, Marie-Ève Beaulieu, et al.
Pageof 14